Latest 10-Q quarterly reports

XBiotech Inc. filed its Q2 2026 Form 10-Q, detailing ongoing research and development efforts, continued net losses, and a cash position of $109.5 million.

Ohio Valley Banc Corp. announced its financial results for the six months ended June 30, 2026, reporting a decrease in net income and earnings per share compared to the same period in 2025, primarily due to higher provision for credit losses and increased noninterest expenses.

Virginia National Bankshares Corporation announced a substantial increase in net income for the second quarter and first half of 2026, driven by a significant gain on investment and improved operational efficiencies.

Gulf Coast Ultra Deep Royalty Trust reports no royalty income and no distributable income for unitholders as the sole producing well has been plugged and abandoned.

Wolverine World Wide, Inc. announced its second quarter 2026 results, showcasing a 6.8% increase in revenue and a rise in diluted EPS to $0.37.

Sativus Tech Corp.'s Q2 2026 Form 10-Q highlights significant financial challenges, including a substantial accumulated deficit and negative operating cash flow, raising serious concerns about its ability to continue as a going concern.

F&M Bank Corp. announced a substantial increase in net income for the second quarter of 2026, driven by robust loan growth and a significant gain from the sale of an investment.

King Resources, Inc. disclosed a substantial net loss of $962,587 for the first quarter of 2026, with no revenue generated during the period, a stark contrast to the prior year's performance.

International Land Alliance reported a net loss of $6.7 million for the six months ended June 30, 2026, and faces substantial doubt regarding its ability to continue as a going concern.

Odysight.ai Inc. filed its Q2 2026 Form 10-Q, reporting a substantial year-over-year decrease in revenue for the six-month period, alongside continued operating losses.

Comstock Holding Companies, Inc. announced a substantial 74.1% increase in revenue for the second quarter of 2026, driven by expanded managed portfolios and strategic real estate ventures.

UMeWorld Inc. reported a significant increase in revenue for the third quarter of 2026, driven by Asia-Pacific expansion, but also a substantial rise in net loss and a working capital deficiency, raising going concern issues.

RMX Industries, Inc. filed its Q2 2026 Form 10-Q, revealing a sharp 89% revenue decrease and a significant increase in net loss, while highlighting ongoing concerns about its ability to continue as a going concern.

Lifeway Foods, Inc. announced a 24.1% increase in net sales for Q2 2026, driven by higher kefir volumes, but reported a significant drop in net income and gross profit margin due to rising milk and packaging costs.

Cyabra, Inc. disclosed a significant increase in net loss for the six months ended June 30, 2026, alongside substantial doubts regarding its ability to continue as a going concern, despite a 26% rise in revenue.

Cingulate Inc. reported a significant increase in operating expenses and net loss for the six months ended June 30, 2026, alongside a Complete Response Letter from the FDA for its lead drug candidate, CTx-1301.

Ategrity Specialty Insurance Company Holdings announced significant increases in gross written premiums and net earned premiums for the second quarter of 2026, alongside improved profitability and a lower expense ratio.

EquipmentShare.com Inc. reported a significant increase in revenue and improved net income for the second quarter of 2026, driven by expansion and strong demand in equipment rental services.

1RT Acquisition Corp. reports on its financial condition and operational status as it continues its search for a business combination, highlighting interest income and ongoing administrative costs.

SPAR Group reported a decrease in net revenue for the second quarter of 2026, alongside a net loss, primarily driven by a slowdown in its remodel business.

Fate Therapeutics, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing continued operational expenses and net losses.

Ovid Therapeutics Inc. filed its Form 10-Q for the period ended June 30, 2026, detailing continued operating losses and a strong reliance on capital raises to fund its biopharmaceutical development.

HeartCore Enterprises, Inc. reported a net loss of $2.04 million for the second quarter of 2026, a significant increase from the prior year's net income, driven by rising costs and the impact of discontinued operations.

Nakamoto Inc. disclosed significant goodwill impairments totaling $105.2 million and a substantial net loss of $133.0 million for the quarter ended June 30, 2026, primarily driven by digital asset value declines and acquisition-related charges.

Caring Brands, Inc. reported no revenue for the quarter ended June 30, 2026, alongside significant operating losses and a recent delisting determination from the Nasdaq Stock Market.

K2 Capital Acquisition Corp. reported net income for the second quarter of 2026, primarily driven by interest earned on its trust account, while continuing its search for a business combination.

Duke Robotics Corp. reports on its Q2 2026 performance, highlighting a successful Nasdaq listing and significant capital infusion, while navigating operational challenges and geopolitical instability.

Candel Therapeutics announced positive topline data from its Phase 3 prostate cancer trial and updated data for NSCLC and pancreatic cancer, while also detailing its financial position and ongoing capital requirements.

MeiraGTx Holdings plc announced a substantial increase in revenue for the six-month period ended June 30, 2026, driven by strategic collaborations and a robust cash position, while continuing to invest heavily in its gene therapy pipeline.

National Vision Holdings reported a 2.5% increase in Q2 revenue to $498.8 million, driven by new store sales and comparable store growth, alongside improved profitability metrics.